We previously reported that a high left atrial (LA) pressure is associated with LA stiffness and poor rhythm outcomes after de novo catheter ablation of atrial fibrillation. Herein, we investigated whether radiofrequency catheter ablation generally changes the LA pressure among patients undergoing repeat procedures.
R
adiofrequency catheter ablation (RFCA) of atrial fibrillation (AF) not only reduces the mortality and hospitalization rates in patients associated with heart failure 1 but also has a positive effect on reducing the risk of a stroke 2 and improving the cognitive function. 3 The restoration and maintenance of sinus rhythm (SR) after AF catheter ablation is associated with reverse remodeling of the left atrial (LA) size, 4, 5 and an improvement in the left ventricular (LV) systolic and diastolic function, 6 and microvascular function. 7 However, it is also true that RFCA of AF is a destructive procedure that damages the cardiac tissue. Radiofrequency energy delivery to the LA proper, especially away from the pulmonary veins (PVs), contributes to the formation of atrial fibrotic scar tissue. Stiff LA syndrome was initially reported in patients who had developed pulmonary hypertension after cardiac surgery. 8 Similar findings were reported in patients who underwent extensive AF catheter ablation. 9 We previously demonstrated that a high LA pressure (LAP) was associated with LA stiffness and poor rhythm outcomes in patients who underwent AF catheter ablation. 10, 11 However, there has been no study directly measuring the LAP or LA compliance after AF catheter ablation. Therefore, we hypothesized that AF catheter ablation, especially extra-PV LA ablation, would increase the LAP and reduce the LA compliance. The purpose of this study was to compare the changes in the LAP and LA compliance in patients who underwent repeat AF ablation procedures and to evaluate the relationships to the de novo ablation method, patient symptoms, and prognosis.
METHODS
The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Study Population
This study protocol adhered to the principles of the Declaration of Helsinki and was approved by the Institutional Review Board at the Yonsei University Health System. All patients provided written informed consent for inclusion in the Yonsei AF Ablation Cohort Database (URL: https://www.clinicaltrials. gov; unique identifier: NCT02138695). Among 1848 patients who underwent a de novo procedure and measurement of the LAP at the beginning of the RFCA from September 2010 to October 2017, 1687 patients (59±11 years, 72.4% men, 72.8% paroxysmal AF) in whom the LAP was measured during SR after the transseptal puncture were included in the study (Figure 1) . Among the 1687 patients, 142 underwent a redo procedure for antiarrhythmic resistant recurrent AF and had their LAP measured during SR. Finally, with a consecutive follow-up, 3 patients underwent multiple procedures (>2 ablation sessions) and LAP measurements. The exclusion criteria of this study were as follows: (1) permanent AF refractory to electrical cardioversion, (2) AF with valvular disease ≥grade 2, (3) prior cardiac surgery with concomitant AF surgery or AF catheter ablation, and (4) an unmeasurable LAP during SR due to the frequent reinitiation of AF.
Echocardiographic and Cardiac Computed Tomographic Evaluation
All patients underwent transthoracic echocardiography before the de novo and redo procedures. The LA dimension, LV ejection fraction, peak transmitral flow velocity (E), and tissue Doppler echocardiography of the peak septal mitral annular velocity (Em) and LV mass index were obtained according to the American Society of Echocardiography guidelines. Three-dimensional (3D) spiral computed tomography scans (64 Channel, LightSpeed Volume CT, Philips, Brilliance 63; Amsterdam, the Netherlands) were conducted to define the PV anatomy. The 3D spiral computed tomography images of the LA were analyzed on an imaging processing workstation
WHAT IS KNOWN?
• The catheter ablation of atrial fibrillation results in atrial scars, and extensive left atrial fibrosis may increase the risk of the stiff left atrial syndrome.
• Elevated left atrial pressure is closely associated with electroanatomical remodeling of the left atrium and is an independent predictor for atrial fibrillation recurrence after catheter ablation in patients with a structurally and functionally normal heart.
WHAT THE STUDY ADDS?
• Atrial fibrillation catheter ablation, especially extensive extrapulmonary vein left atrial ablation, increases the left atrial stiffness and is associated with a worsening postablation diastolic function.
• However, symptom score did not significantly change after atrial fibrillation ablation in spite of elevation of left atrial pressure in the majority of the patients. (Aquarius; TeraRecon, Inc, Foster City, CA). For regional volumetric analyses, each LA image was subdivided according to the embryological origin as follows: venous LA, anterior LA, and LA appendage.
LAP Measurements
The intracardiac electrograms and hemodynamic measurements were recorded using the Prucka Cardio Lab electrophysiology system (General Electric Medical Systems, Inc, Milwaukee, WI). A double transseptal puncture approach was taken for catheter access to the LA. The LAP was measured during SR immediately after the transseptal puncture using a 6F pigtail catheter (A&A Medical Device, Inc, Gyeonggi-do, Republic of Korea) that was inserted into the LA through a long sheath (Schwartz left 1; St. Jude Medical, Inc, Minnetonka, MN). If the initial rhythm was AF, we measured the LAP during SR after terminating the AF by internal cardioversion (2-10 J biphasic shocks, Lifepak12; Physiocontrol, Ltd, Redmond, WA), followed by at least a 3-minute waiting period to allow for recovery from atrial stunning from the cardioversion. We analyzed the LA peak pressure (LAP peak ; v wave), LA nadir pressure (LAP nadir ; x wave), LA mean pressure (LAP mean ), and LA pulse pressure (LA pp ; the difference between the LAP peak and LAP nadir ). Those parameters have been defined and calculated in our previous study.
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Electroanatomical Mapping and RFCA
The 3D electroanatomical mapping (NavX; St. Jude Medical, Inc) was generated using a circumferential PV mapping catheter (Lasso; Biosense Webster, Inc, Diamond Bar, CA) through a long sheath (Schwartz left 1; St. Jude Medical, Inc). The 3D geometry of both the LA and PV was generated using the NavX system and then merged with the 3D spiral computed tomography images. With blind patient information, a technician analyzed the color-coded computed tomography-merged NavX voltage maps using customized software (Image Pro; Media Cybernetics, Inc, Rockville, MD was used for the RFCA. All patients underwent a de novo procedure with a circumferential PV isolation (CPVI). The majority of the patients (93.5%) underwent the creation of cavotricuspid isthmus block during the de novo procedure, unless there was atrioventricular conduction disease. As an extra-PV LA ablation, we conducted additional linear ablation including a roofline, posterior inferior line (posterior box lesion), and anterior line, especially in patients with persistent AF. A left lateral isthmus ablation, right atrial ablation, and complex fractionated electrogram ablation were performed in the minority of patients at the operator's discretion. We defined an extra-PV LA ablation as additional linear ablation with or without a complex fractionated electrogram ablation following the CPVI. The de novo procedure ended when there was no immediate recurrence of AF within 10 minutes after the cardioversion with an isoproterenol infusion (5-10 μg/min).
Postablation Management and Follow-Up
The patients visited the outpatient clinic at 1, 3, 6, and 12 months and every 6 months thereafter or whenever symptoms developed after the RFCA. Electrocardiography was performed at every visit. Twenty-four-hour Holter monitoring was performed at 3, 6, and 12 months and then every 6 months according to the 2012 Heart Rhythm Society/European Heart Rhythm Association/European Cardiac Arrhythmia Society Expert consensus statement guidelines. 12 Patients who experienced symptoms of palpitations underwent Holter/ event-monitor examinations to investigate the possibility of arrhythmia recurrence. We defined AF recurrence as any episode of atrial tachycardia or AF lasting for ≥30 seconds. Any electrocardiography documentation of AF recurrence after a 3-month blanking period was classified as a clinical recurrence.
Quality-of-Life Measurements
To investigate the quality of life (QOL) in the patients who underwent RFCA, we administered the EuroQol-five dimensions (EQ-5D) questionnaire, including a 3-level severity on 5 dimensions describing the mobility, self-care, usual activities, pain/ discomfort, and anxiety/depression before the first and second ablation procedures and after the last ablation procedure. 13 The EQ-5D index score was calculated by a previously reported method with a score ranging from −0.594, representing the worst health status, to 1.000, for a fully healthy condition. 14 
Statistical Analysis
Continuous variables are expressed as the mean±SD. Categorical variables are reported as the count (percentage). We compared the LAP between the de novo and redo procedures to investigate whether the LAP increased after the de novo procedure by using a paired t test. We investigated the factors for an increase in the LAP after a de novo procedure using univariate and multivariate linear regression analyses. We used a linear regression analysis to investigate the clinical and invasive parameters associated with the LV diastolic function after the RFCA. A repeated measures ANOVA was used to investigate the EQ-5D index score changes according to the number of RFCA sessions. We used a Student t test to compare the EQ-5D index score and LAP. A P <0.05 was considered statistically significant. All statistical analyses were performed using SPSS (Statistical Package for Social Sciences, Chicago, IL) software for Windows (version 23.0).
RESULTS
AF Ablation Increases the LAP
The baseline characteristics of the patients included are presented in Table 1 . The LAP changes in the same 142 patients during the de novo procedures and redo procedures are summarized in Table 2 . After the de novo procedure, the mean LAP peak (P<0.001) and LA pp (P<0.001) were significantly increased during the redo procedures. Figure 2 shows a consistent increase in the mean LAP peak (P<0.001) and LA pp (P<0.001) during SR after the de novo procedures. The patients with an exceptionally reduced LAP during the redo procedure had underlying tachycardiomyopathy or AF-induced cardiomyopathy, and the LV function remarkably improved after the de novo procedure. To exclude any atrial stunning effect, we compared the LAPs in 35 patients who were initially in SR during both the de novo and repeat procedures, and the LA pp changes (14.7±6.8 to 19.5±7.8 mm Hg; P=0.002) were consistent with the overall patient group (Figure I in the Data Supplement). Figure 3 shows the comparisons of the LAP changes between the patients who underwent a CPVI alone and those with additional extra-PV LA ablation. Even after the CPVI alone during the de novo procedure, both the LAP peak (20 (Table 4) .
Extra-PV LA Ablation Increases the LA Stiffness
Catheter Ablation and the QOL
Among 142 patients, 102 perfectly completed the EQ-5D questionnaire (Table III in 
DISCUSSION
Major Findings
We found that AF catheter ablation increased the LAP and LA stiffness. Extensive extra-PV LA ablation was independently associated with an increased LA stiffness during the repeat ablation procedures. The increase in the LA stiffness estimated by the LA pp was closely related to the LV filling pressure (estimated by the E/Em) Table I in the Data Supplement. △LA pp indicates the degree of the increase in the left atrial pulse pressure; E/Em, the ratio of the early diastolic mitral inflow velocity (E) to the early diastolic mitral annular velocity (Em); LA, left atrium; LVMI, left ventricular mass index; and SR, sinus rhythm.
*Multivariate model 2 focused on the clinical characteristics and invasive parameters of the patients, including the age, sex, and LA pressure.
†Statistical significance.
immediately before the repeat procedure. An accurate, efficient, and limited radiofrequency lesion set was, therefore, required to avoid any unnecessary hemodynamic burden after the AF catheter ablation. However, an increased LAP did not significantly affect the QOL scores, and rhythm control by repeat procedures improved the QOL scores.
Extensive AF Ablation and a Reduced LA Compliance
Stiff LA syndrome was initially reported in patients who underwent cardiac surgery 8 and was defined as post-operative symptomatic pulmonary hypertension in the setting of an LAP elevation without any valve dysfunction. Because large LA scar tissue contributes to the stiff LA syndrome, extensive catheter ablation of AF may induce a stiff LA physiology with a low incidence (about 1.4%), 9 especially in patients with preexisting LA scar, 9 a prolonged ablation time, 15 and repeat ablation sessions. 16 In general, the persistence of AF accompanies atrial structural remodeling that includes fibrosis, interstitial matrix changes, and the appearance of arrhythmogenic myofibroblasts, 17 associated with LA enlargement, 18 an endocardial voltage reduction, 19 late gadolinium enhancement in the cardiac magnetic resonance imaging, 20 and a high LAP. 10, 11 However, a large number of those patients experience recurrent AF after catheter ablation because of a high LAP-related mechanoelectrical feedback 21 or stretch-induced profibrotic reactions. 22 To reduce the AF recurrence rate, operators tend to perform a more extensive empirical ablation, but more ablation lesions result in more scarring. However, recent clinical studies have revealed no additional benefit of linear ablation, electrogram-guided ablation, or scar homogenization compared with a CPVI alone. 23, 24 In the current study, extra-PV LA ablation was an independent predictor of a reduction in the post-AF ablation LA compliance. Therefore, an empirical extensive extra-PV LA ablation might be a destructive procedure and worsen the LA stiffness without better rhythm outcomes. The high chance of a recurrence after a CPVI alone in patients with persistent AF remains a significant challenge to solve in the future.
LA Stiffness and LV Diastolic Function
AF is commonly associated with heart failure and increases the heart failure mortality 2.7×. 25 Because of the hemodynamic linkage between the LV and LA through diastolic mitral valve opening, 26 an LAP overload due to LV dysfunction may cause LA fibrosis and dilatation of the thin-walled LA rather than atrial hypertrophy. 27 We previously demonstrated an independent association to the E/Em, which reflects the LV filling pressure or LV diastolic function, by directly measuring the LAP. 10 On the contrary, the change in the LA function and LAP can affect the LV systolic and diastolic function. Kim et al 6 reported that a preablation low E/ Em predicts an improvement in the LV systolic function, and a high baseline E/Em predicts the improvement in the LV diastolic function 1 year after AF catheter ablation. Although restoring SR by AF ablation generally improves the LA function, excessive LA ablation or underlying LA myopathy can result in negative effects on the LA and LV function. 4, 28 The LA is not a simple passive transporter but a highly dynamic chamber functioning as a reservoir, conduit, and booster pump. 29 An increase in the LA stiffness may decrease the roles of the reservoir and booster pump, leaving the LA as a simple conduit with a high LAP delivered directly to the LV and with a negative effect on the LV filling pressure and LV diastolic function. Therefore, LA stiffness and worsening of the LV diastolic function affect each other. 10, 30 LA Stiffness and the QOL Catheter ablation of AF as a first-or second-line therapy has been shown to improve the QOL in previous studies. 31, 32 Although there were some patients without clinical recurrence after a second ablation procedure, this study demonstrated an upward trend in the improvement in the symptoms according to the number of RFCA sessions despite a parallel modest increase in the LAP. Because an increased LA stiffness during repeat procedures is not the same as the stiff LA syndrome, there was no significant difference in the QOL between the patients without a reduced LA compliance and those with a reduced LA compliance after the AF ablation procedure. In this study, an empirical extra-PV LA ablation did not further worsen the QOL after the de novo procedure, as compared with a CPVI alone. However, the EQ-5D was a generic questionnaire and may not reflect the minimal symptomatic changes during exercise in patients with an elevated LAP, which is closely associated with the E/Em.
Limitations
This study had several limitations. It was an observational cohort study from a single center that included highly selected patients referred for AF ablation and had a limited number of patients. Because the LAP is sensitive to the volume status, we measured the LAP at the beginning of the procedure after overnight fasting to exclude the volume effect after the RFCA. Nonetheless, the fasting times of the first procedure and repeat procedure may have differed. Patients with significant structural heart disease were not included in this study. An endhole pressure sensor catheter was not used to measure the LAP. Instead, we used a 6F pigtail catheter to conduct this clinical study because of the limited medical insurance coverage. We measured the LAP during SR after cardioversion in patients with an initial AF rhythm state. Although we waited for at least 3 minutes for the LAP to stabilize, it might have been difficult to exclude the stunning effects on the LA. Although we measured the LV filling pressure estimated by the E/Em immediately before the second procedure, there could have been a time discrepancy in the measurement between the LAP and E/Em during the second procedure.
Conclusions
AF catheter ablation increases the LAP and LA stiffness. Extensive extra-PV LA ablation is independently associated with an increased LA stiffness during repeat ablation procedures without worsening the QOL. An accurate, efficient, and limited radiofrequency lesion set is, therefore, required to avoid any unnecessary hemodynamic burden after AF catheter ablation. 
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